| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Strategic Planning > The Disintermediation of New Technologies |
|
E-Folder - The Disintermediation of New Technologies
In economics, disintermediation is the removal of intermediaries in a supply chain. Disintermediation is often the result of high market transparency, in that buy According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ers are aware of supply prices direct from the manufacturer. As a result, buyers bypass the middlemen (wholesalers and retailers) in order to buy directly from th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in manufacturer and thereby pay less. Buyers can alternatively elect to purchase from wholesalers, but most often, a buyer-to-consumer intermediary functions as the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. bridge between buyer and manufacturer. A few years ago, scholars wrote that the Internet would "disintermediate" industries or eliminate middlemen. Instead, the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ower cost of selling over the Net and its immense appeal have produced even more middlemen, which helps explain the success of the search giant Google and the onl d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ne marketplace eBay. Technology offers a vast variety of different choices to the end user and the social implications of their adoption create the appropriate a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc tmosphere for people to debate their usefulness and consequences. But whether one is a supporter or an opponent of this technological evolution, the new reality i easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi troduced by the adopted technologies surpassed the creators' intentions and emerged into this new "real" world in which relationships evolve, people exchange info nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically mation, work or even develop themselves as citizens. At the same time, word abbreviations, images, Avatars, icon-bars, virtual reality games or weblogs, are some and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ of the multiple ways with which new technologies have altered the way people interact and have managed to create new subcultures and representations of reality. T ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e adopters of these communication methods relate heavily on the existence and improvement of the used medium, as it must continue to incorporate the advances of o ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a her practices and continuously be updated. Since these recently adopted technology-based practices experience tremendous success, especially among young user gro dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ups, their adoption entails opportunities and threats similar to their predecessors. Contemporary technology evangelists support the proliferation of technologica cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin innovations, along with the extensive usage of these new types of technologies, ideally by the whole world, in order to satisfy the human quest for interconnecti tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ity and belongingness. On the other hand, opponents of this view suggest that these technological breakthroughs are just another type of "imprisonment" and that w t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ill further reduce leisure time, decrease direct face-to-face contact, and will create human "islands." Evaluating the effects of changing communication forms an ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the development of additional channels over the recent years, along with how these developments have altered one's understanding about oneself, has been the topi y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products of research in a variety of studies. Human history is full of numerous examples of clash and integration through which a more advanced synthesis was born. Thus, . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de the issue remains not to cease the questioning and the criticism so as to avoid the uncomfortable "battle zone," but rather to use this criticism constructively a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip d examine the new technological evolutions under the scope that they actually constitute the new tools to evaluate the future implications of today's human praxis tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:5 Good Reasons to Get Out of a Career You Hate Profession of Human Resource Management and Development – Who Should Join and Who Should Not
|